Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein

NCT03462004 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

NIH

Sponsor class

Stopped Cancel Enrollment due to Covid-19 Pandemic, Not restarted

Conditions

Ebola Virus Disease

Interventions

BIOLOGICAL: HPIV3/ΔHNF/EbovZ GP vaccine
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)